Patient No. 32 with Sézary syndrome (SS) (a) before and (b) after treatment with bexarotene. The patient is now on maintenance treatment with 75 mg/day (stable disease). This patient was initially treated for ultraviolet B (UVB)-photosensitivity (and actinic reticuloid), which still persists in the neck and face area. | Ten-year Experience of Bexarotene Therapy for Cutaneous T-cell Lymphoma in Finland – Scientific Figure on ResearchGate. Available from: [accessed 3 Feb, 2020]

Leave a Reply